Clinical Trials Directory

Trials / Completed

CompletedNCT01924676

Food Effect And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers

An Open-label, Single-dose, Randomized, Three-way Crossover Study to Estimate the Effects of Food on Oxycodone Pharmacokinetics Following Oral 40 Mg Doses of PF-00345439 Formulation K and to Estimate Its Relative Bioavailability of Oxycodone Compared to PF-003454390 Formulation X in the Fasted State in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Pain Therapeutics · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

To estimate the effects of food on oxycodone pharmacokinetics after administration of 40 mg doses of PF-00345439 Formulation K and to estimate its relative bioavailability compared to PF-00345439 Formulation X in the fasted state in healthy volunteers

Detailed description

This study will estimate the effect of food (standard high-fat breakfast) on the pharmacokineticsand relative bioavailability of oxycodone following oral administration of single 40 mg doses of PF-00345439 Formulation K in healthy volunteers. Additionally, the study will estimate the pharmacokinetics and relative bioavailability of oxycodone following oral administration of single 40 mg doses of the test PF-00345439 Formulation K compared with the reference PF-00345439 Formulation X under fasted conditions in healthy volunteers and assess the single-dose safety and tolerability of oxycodone in PF-00345439 formulations in healthy volunteers when administered under a naltrexone block.

Conditions

Interventions

TypeNameDescription
DRUGOxycodoneOne capsule of 40 mg PF-00345439 Formulation X, single dose, under fasting conditions
DRUGOxycodoneOne capsule of 40 mg PF-00345439 Formulation K, single dose, under fasting conditions
DRUGOxycodoneOne capsule of 40 mg PF-00345439 Formulation K, single dose, under fed conditions

Timeline

Start date
2013-08-01
Primary completion
2013-10-01
Completion
2013-10-01
First posted
2013-08-16
Last updated
2015-08-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01924676. Inclusion in this directory is not an endorsement.